ImmunoPrecise Antibodies News - IPA

Company Name	Stock Ticker Symbol	Market	Type
ImmunoPrecise Antibodies Ltd	IPA	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	1.24	04:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
				1.24

more quote information »

Recent News

Date	Time	Source	Heading
3/28/2024	14:35	BW	InterSystems et BioStrand, filiale d’IPA, collaborent au..
3/28/2024	07:02	BW	InterSystems and IPA’s Subsidiary BioStrand Collaborate to..
3/20/2024	13:52	BW	IPA acquiert l'instrument Carterra LSA® pour améliorer la..
3/20/2024	07:02	BW	IPA Acquires the Carterra LSA® Instrument to Enhance..
3/14/2024	19:39	BW	IPA présente ses résultats financiers et les récents points..
3/14/2024	08:05	BW	IPA Reports Financial Results and Recent Business Highlights..
3/07/2024	15:24	BW	BioStrand, filiale d'IPA, annonce une avancée majeure dans..
3/07/2024	11:19	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
3/07/2024	07:02	BW	IPA’s subsidiary BioStrand Unveils Major Breakthrough in..
3/04/2024	16:50	BW	L'IPA publiera ses résultats financiers et les faits..
3/04/2024	08:01	BW	IPA to Report Financial Results and Recent Business..
2/23/2024	17:29	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/23/2024	17:26	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2/15/2024	15:12	EDGAR2	Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
1/10/2024	13:53	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
1/10/2024	13:33	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
12/14/2023	15:08	BW	IPA présente ses résultats financiers et les récents points..
12/14/2023	08:48	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/14/2023	08:38	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/14/2023	08:03	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/14/2023	08:01	BW	IPA Reports Financial Results and Recent Business Highlights..
12/08/2023	21:57	BW	IPA annonce la clôture d'une offre publique d'actions..
12/08/2023	17:11	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/08/2023	17:00	BW	IPA Announces Closing of $1.265 Million Public Offering of..
12/07/2023	16:53	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
12/06/2023	17:19	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/06/2023	07:57	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/06/2023	07:00	BW	IPA annonce le prix des actions ordinaires de son émission..
12/06/2023	06:01	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/05/2023	20:22	BW	IPA annonce une proposition d'offre publique d'actions..
12/05/2023	16:35	BW	IPA Announces Proposed Public Offering of Common Shares
12/05/2023	16:02	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
11/27/2023	13:09	BW	ImmunoPrecise Antibodies Ltd annonce des nominations clés au..
11/27/2023	08:31	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/27/2023	08:01	BW	ImmunoPrecise Antibodies Ltd. Announces Key Board and Board..
11/16/2023	17:13	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/13/2023	14:09	BW	BioStrand® dévoile une approche révolutionnaire de la..
11/13/2023	08:50	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/13/2023	08:32	BW	BioStrand® Unveils a Revolutionary Approach to Biological..
10/25/2023	12:12	BW	BioStrand, filiale de l'IPA, fait le point sur LENSai™
10/25/2023	08:01	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/25/2023	08:01	BW	IPA’s Subsidiary, BioStrand, Provides an Update on LENSai™
10/23/2023	13:36	BW	IPA apporte une mise à jour sur sa stratégie de croissance..
10/23/2023	08:01	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/23/2023	08:01	BW	IPA Provides Update on Growth Strategy and Recent Share..
10/20/2023	14:56	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/26/2023	11:56	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/25/2023	16:46	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/19/2023	12:34	BW	ImmunoPrecise Antibodies annonce le remplacement de son..
9/19/2023	08:02	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..